Epix Soars 50% On Alzheimer's Data

clipped from blogs.forbes.com EPIX Pharmaceuticals (NASDAQ: EPIX - News), today announced compelling top-line results from a Phase 2a two-week clinical trial of its novel 5-HT4 agonist, PRX-03140, in patients with Alzheimer’s disease. The results show that patients receiving 150 mg of PRX-03140 orally once daily as monotherapy achieved a mean 5.7 point improvement on the Alzheimer’s Disease Assessment Scale cognitive subscale (ADAS-cog) versus a 0.2 point worsening in patients on placebo (p= 0.005). Patients on a 50 mg dose of PRX-03140 showed a 1.1 point improvement on the ADAS-cog. After reviewing these data, Serge Gauthier, M.D., Director of the Alzheimer's Disease Research Unit at McGill University, stated, “There is such an urgent and undeniable need for additional safe and effective treatments for Alzheimer’s patients. Findings like these data are not only encouraging and compelling – they appear to represent a step forward in our ability to understand and combat the effects of Alzheimer’s.

Dumbest Business of 2007

See this one, Jessica Simpson and others by following the link.

clipped from money.aol.com Made (Badly) in China Grand Prize Winner During 2007, Mattel recalls almost 20 million items made in China because of lead paint and tiny magnets. Pet food makers recall more than 360 million cans of tainted food from China. Chinese-made lunch boxes given away to promote healthy eating among children are found to contain lead. And so on ... and so on ... and so on. · See More China Messes

Start-Up Sells Solar Panels at Lower-Than-Usual Cost

clipped from www.nytimes.com

Nanosolar, a heavily financed Silicon Valley start-up whose backers include Google’s co-founders, plans to announce Tuesday that it has begun selling its innovative solar panels, which are made using a technique that is being held out as the future of solar power manufacturing.

The company, which has raised $150 million and built a 200,000-square-foot factory here, is developing a new manufacturing process that “prints” photovoltaic material on aluminum backing, a process the company says will reduce the manufacturing cost of the basic photovoltaic module by more than 80 percent.

Nanosolar, which recently hired a top manufacturing executive from I.B.M., said that it had orders for its first 18 months of manufacturing capacity. The photovoltaic panels will be made in Silicon Valley and in a second plant in Germany.

Nanosolar has focused on lowering the manufacturing cost

Nanosolar

claims to be the first solar panel manufacturer to be able to

sell solar panels for less than $1 a watt